Healthy AI
Imperial engineer to develop AI clinician to help frontline health workers
Professor Aldo Faisal has won a Turing AI Fellowship to develop AI that will help doctors make complex decisions.
Imperial engineer to develop AI clinician to help frontline health workers
Professor Aldo Faisal has won a Turing AI Fellowship to develop AI that will help doctors make complex decisions.
Chancellor sees cutting-edge medical research at Imperial
The Chancellor visited Imperial's Centre for Translational and Experimental Medicine today after setting out spending plans in Parliament.
Arthritis drug effective in treating sickest COVID-19 patients
Critically ill COVID-19 patients treated with an arthritis drug are significantly more likely to have improved outcomes, a study has found.
Imperial teams compete in second ever ‘bionic Olympics’ from home
After winning a silver medal in the 2016 Cybathlon, Imperial College London is competing again in these ‘bionic Olympics’.
1
Molecular insights into key drug target could help to enhance cancer treatments
New research reveals how a key protein in cells could be tweaked to make cancer treatments more effective.
New anti-cancer drug combo treatment shows promise for myeloma patients
Phase 3 trial results reveal that selinexor – a relatively new anti-cancer drug – improves patient outcomes when combined with established treatments.
Professor Tassos Karadimitris to head myeloma research centre at Imperial
Professor Tassos Karadimitris has been appointed as Langmuir Chair and Director of the Hugh and Josseline Langmuir Centre for Myeloma Research.
Duchess of Cambridge visits Tommy’s Centre for Miscarriage Research at Imperial
Her Royal Highness The Duchess of Cambridge showed her support for Baby Loss Awareness Week, meeting families and experts at Imperial.
Cancer-causing HTLV-1 virus hijacks cellular machinery to establish infection
Scientists have used a cutting-edge visualisation technique to show how the human T-cell lymphotropic virus, type 1 (HTLV-1) infects immune cells.
Mysterious molecular phenomenon could boost precision of targeted drug delivery
Scientists have shown how a type of cellular binding could help pave the way for highly targeted therapies against diseases like cancer.